Breast lumps secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Secondary prevention== | ==Secondary prevention== | ||
Secondary prevention of [[breast lumps]] is the same as primary prevention <ref name="pmid29284222">{{cite journal| author=Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B et al.| title=Primary and secondary prevention of breast cancer. | journal=Ann Agric Environ Med | year= 2017 | volume= 24 | issue= 4 | pages= 549-553 | pmid=29284222 | doi=10.26444/aaem/75943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29284222 }} </ref> | Secondary prevention of [[breast lumps]] is the same as primary prevention.<ref name="pmid29284222">{{cite journal| author=Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B et al.| title=Primary and secondary prevention of breast cancer. | journal=Ann Agric Environ Med | year= 2017 | volume= 24 | issue= 4 | pages= 549-553 | pmid=29284222 | doi=10.26444/aaem/75943 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29284222 }} </ref> | ||
*Surveillance and follow-up to reduce [[breast cancer]] reccurance<ref name="pmid15459225">{{cite journal| author=de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ| title=Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 19 | pages= 4010-8 | pmid=15459225 | doi=10.1200/JCO.2004.06.080 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15459225 }} </ref> | *Surveillance and follow-up to reduce [[breast cancer]] reccurance:<ref name="pmid15459225">{{cite journal| author=de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ| title=Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review. | journal=J Clin Oncol | year= 2004 | volume= 22 | issue= 19 | pages= 4010-8 | pmid=15459225 | doi=10.1200/JCO.2004.06.080 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15459225 }} </ref> | ||
**History and clinical physical examination required every 4 to 6 months for 5 years | **History and clinical physical examination required every 4 to 6 months for 5 years | ||
**Annual [[mammography]] and clinical physical examination after first 5 years | **Annual [[mammography]] and clinical physical examination after first 5 years |
Revision as of 16:06, 7 January 2019
Breast lumps Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Breast lumps secondary prevention On the Web |
American Roentgen Ray Society Images of Breast lumps secondary prevention |
Risk calculators and risk factors for Breast lumps secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Secondary prevention of breast lumps is the same as primary prevention. In order to reduce breast cancer reccurance, surveillance and follow-up by either physical examination and mammography are required.
Secondary prevention
Secondary prevention of breast lumps is the same as primary prevention.[1]
- Surveillance and follow-up to reduce breast cancer reccurance:[2]
- History and clinical physical examination required every 4 to 6 months for 5 years
- Annual mammography and clinical physical examination after first 5 years
- Annual gynecological assessment for uterus evaluation for women on tamoxifen
- Bone health assessment for women on aromatase inhibitor and those who had ovarian failure secondary to treatment
- Establishment of physical activity, alcohol intake, weight gain
References
- ↑ Kolak A, Kamińska M, Sygit K, Budny A, Surdyka D, Kukiełka-Budny B; et al. (2017). "Primary and secondary prevention of breast cancer". Ann Agric Environ Med. 24 (4): 549–553. doi:10.26444/aaem/75943. PMID 29284222.
- ↑ de Bock GH, Bonnema J, van der Hage J, Kievit J, van de Velde CJ (2004). "Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: a meta-analysis and systematic review". J Clin Oncol. 22 (19): 4010–8. doi:10.1200/JCO.2004.06.080. PMID 15459225.